Trial intelligence / Profile preview

Systemic antibiotics versus placebo after implant surgery with guided bone regeneration and simultaneous sinus floor elevation

2021-001885-40Phase 4Active

Sponsor
Complutense University of Madrid
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of amoxicillin in edentulism and None (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: Patient-reported outcome measures. Started Dec 2024; status: active.

02

Drugs

amoxicillin
03

Conditions

edentulism

Beyond the preview

Go deeper on 2021-001885-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-001885-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call